Target intelligence / Profile preview

Phosphate transporter

Molecular classification
Transporter, Ion transporter, Solute carrier (SLC) family protein
01

Overview

Phosphate transporters are integral membrane proteins that mediate the movement of inorganic phosphate ions across biological membranes in cells, playing critical roles in systemic and cellular phosphate homeostasis[8][3][4]. The two main families involved are the SLC34 (NaPi-II) and SLC20 (PiT) sodium-dependent phosphate cotransporters, which are responsible for intestinal absorption, renal reabsorption, and uptake into various tissues[3][4]. These transporters are regulated by hormonal and metabolic cues and are implicated in disorders of bone, kidney, and mineral metabolism[3][4][8][10]. Phosphate ion transport is thus a key physiological process and the transporters mediating this function are valid molecular drug targets in diseases involving disturbed phosphate regulation.

Other names
Sodium-dependent phosphate transporterNaPi-IIa/b/cPiT-1PiT-2SLC34SLC20
02

Mechanism of action

Inhibition or enhancement of phosphate uptake through modulation of transporter activity Alteration of transporter expression (e.g., by vitamin D analogs, parathyroid hormone)

03

Biological functions

Phosphate homeostasisBone mineralizationRenal phosphate reabsorptionIntestinal phosphate absorptionCellular metabolism
04

Disease associations

Chronic kidney diseaseHypophosphatemiaHyperphosphatemiaBone diseases (e.g., rickets, osteomalacia)Vascular calcification
05

Safety considerations

Altered transporter activity can cause severe electrolyte imbalanceRisk of hypophosphatemia (muscular, neurological, hematologic symptoms)Excess transporter activity leads to hyperphosphatemia, risk of vascular calcification, and cardiovascular disease in chronic kidney disease
06

Interacting drugs

Phosphate binders (e.g., sevelamer, lanthanum carbonate, calcium acetate indirectly affect extracellular phosphate levels)

1 more in the full profile.

07

Biomarkers

Blood phosphate levelUrinary phosphate excretionSerum fibroblast growth factor 23 (FGF23)Expression levels of transporter proteins (SLC34A1/2, SLC20A1/2) in tissue (mainly research setting)

Beyond the preview

Go deeper on Phosphate transporter.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphate transporter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call